Zielinski's research focuses on clinical trials in breast and lung cancer as well as personalised medicine and immuno-oncology. Christoph Zielinski is President of the Central European Cooperative Oncology Group (CECOG). As of late 2018 he had published more than 600 original publications and reviews. His h-index exceeds 60.